Systems and methods for personalized clinical applications of accelerated theta-burst stimulation
Systems and methods for treatment of neurological conditions using aTBS in accordance with embodiments of the invention are illustrated. One embodiment includes a method for treating neurological conditions, including generating a personalized accelerated theta burst stimulation (aTBS) target representing a location in a patient's brain related to a neurological condition, placing a TMS device relative to the patient's brain such that the focus of the magnetic field is over the aTBS target, applying TMS to the aTBS target according to an aTBS protocol to the brain using the TMS device to alleviate the neurological condition.
1. A method for treating neurological conditions, comprising:
applying accelerated intermittent theta burst stimulation (aiTBS) to a target brain structure using a transcranial magnetic stimulation (TMS) device in order to treat a neurological condition, wherein the TMS device is controlled using a processor configured by an application stored in a memory;
wherein the aiTBS comprises:
a plurality of sessions on a given day;
wherein during each session in the plurality of sessions, the TMS device is controlled by the processor to apply magnetic neurostimulation comprising a plurality of pulse trains separated by an intertrain interval; and
wherein each session in the plurality of sessions is separated by an intersession interval lasting between 25 and 120 minutes during which the TMS device is controlled by the processor to provide no magnetic neurostimulation.
2. The method of claim 1 , wherein each pulse train comprises magnetic pulses having a frequency between 20 Hz and 70 Hz, and wherein the magnetic pulses are applied at a frequency between 3 Hz to 7 Hz.
3. The method of claim 1 , wherein the intertrain interval lasts between 4 to 10 seconds; and
wherein each session in the plurality of sessions lasts between 3 and 15 minutes.
4. The method of claim 1 , wherein the plurality of sessions comprises between 3 and 15 sessions.
5. The method of claim 1 , wherein each pulse train in the plurality of pulse trains lasts for 2 seconds; and
wherein each pulse train in the plurality of pulse trains comprises magnetic pulses in the form of three, 50 Hz pulses applied at 5 Hz, where the intertrain interval is 10 seconds; and
wherein the plurality of sessions comprises at least ten, 10-minute sessions; and
wherein the intersession interval is 50 minutes.
6. The method of claim 1 , wherein the neurological condition is clinical depression.
7. The method of claim 1 , wherein the neurological condition is suicidal ideation.
8. A method for treating neurological conditions, comprising:
applying accelerated continuous theta burst stimulation (acTBS) to a target brain structure using a transcranial magnetic stimulation (TMS) device in order to treat a neurological condition, wherein the TMS device is controlled using a processor configured by an application stored in a memory;
wherein the acTBS comprises:
a plurality of sessions on a given day;
wherein during each session in the plurality of sessions, the TMS device is controlled by the processor to apply magnetic neurostimulation comprising a plurality of pulse trains; and
wherein each session in the plurality of sessions is separated by an intersession interval lasting between 10 and 50 minutes during which the TMS device is controlled by the processor to provide no magnetic neurostimulation.
9. The method of claim 8 , wherein each pulse train comprises magnetic pulses having a frequency between 20 Hz and 70 Hz, and wherein the magnetic pulses are applied at a frequency between 3 Hz to 7 Hz; and
wherein each session in the plurality of sessions lasts between 40 and 44 seconds.
10. The method of claim 8 , wherein the plurality of sessions comprises between 10 and 40 sessions.
11. The method of claim 8 , wherein each session in the plurality of sessions for a given day comprises a set of 3-pulse trains, wherein each pulse is 50 Hz applied at 5 Hz; and wherein each session in the plurality of sessions lasts 40 seconds.
12. The method of claim 8 , wherein the plurality of pulse trains comprises three-pulse trains, wherein each pulse in each three-pulse train is 30 Hz;
wherein pulses in each three-pulse train are applied at 6 Hz; and
wherein each session in the plurality of sessions lasts 44 seconds.
13. The method of claim 8 , wherein the neurological condition is clinical depression.
14. The method of claim 8 , wherein the neurological condition is suicidal ideation.
15. A system for treatment of neurological conditions, comprising:
a transcranial magnetic stimulation device;
a processor; and
a memory containing an application which configures the processor to control the transcranial magnetic stimulation device to apply accelerated intermittent theta burst stimulation (aiTBS) to a target brain structure in order to treat a neurological condition;
wherein the aiTBS comprises:
a plurality of sessions on a given day;
wherein during each session in the plurality of sessions, magnetic neurostimulation is applied in the form of a plurality of pulse trains separated by an intertrain interval; and
wherein each session in the plurality of sessions is separated by an intersession interval lasting between 25 and 120 minutes during which no magnetic neurostimulation is applied.
16. The system of claim 15 , wherein each pulse train comprises magnetic pulses having a frequency between 20 Hz and 70 Hz; and
wherein the magnetic pulses are applied at a frequency between 3 Hz to 7 Hz.
17. The system of claim 15 , wherein the intertrain interval lasts between 4 to 10 seconds; and
wherein each session in the plurality of sessions lasts between 3 and 15 minutes.
18. The system of claim 15 , wherein the plurality of sessions comprises between 3 and 15 sessions.
19. The system of claim 15 , wherein each pulse train in the plurality of pulse trains lasts for 2 seconds; and
wherein each pulse train in the plurality of pulse trains comprises pulses in the form of three, 50 Hz pulses applied at 5 Hz, where the intertrain interval is 10 seconds; and
wherein the plurality of sessions comprises at least ten, 10-minute sessions; and
wherein the intersession interval is 50 minutes.
20. The system of claim 15 , wherein the neurological condition is clinical depression.
21. The system of claim 15 , wherein the neurological condition is suicidal ideation.
22. A system for treatment of neurological conditions, comprising:
a transcranial magnetic stimulation device;
a processor; and
a memory containing an application which configures the processor to control the transcranial magnetic stimulation device to apply accelerated continuous theta burst stimulation (acTBS) to a target brain structure in order to treat a neurological condition;
wherein the acTBS comprises:
a plurality of sessions on a given day;
wherein during each session in the plurality of sessions, magnetic neurostimulation is applied in the form of a plurality of pulse trains; and
wherein each session in the plurality of sessions is separated by an intersession interval lasting between 10 and 50 minutes during which no magnetic neurostimulation is applied.
23. The system of claim 22 , wherein each pulse train comprises magnetic pulses having a frequency between 20 Hz to 70 Hz
wherein the magnetic pulses are applied at a frequency between 3 Hz to 7 Hz; and
wherein each session in the plurality of sessions lasts between 40 and 44 seconds.
24. The system of claim 22 , wherein the plurality of sessions comprises between 10 and 40 sessions.
25. The system of claim 22 , wherein each session in the plurality of sessions for a given day comprises a set of 3-pulse trains, wherein each pulse is 50 Hz applied at 5 Hz; and wherein each session in the plurality of sessions lasts 40 seconds.
26. The system of claim 22 , wherein the plurality of pulse trains comprises three-pulse trains, wherein each pulse in each three-pulse train is 30 Hz;
wherein pulses in each three-pulse train are applied at 6 Hz; and
wherein each session in the plurality of sessions lasts 44 seconds.
27. The system of claim 22 , wherein the neurological condition is clinical depression.
28. The system of claim 22 , wherein the neurological condition is suicidal ideation.